Property Name |
Property Value |
Unit |
Raw Value |
Raw Unit |
Annotation |
Reference |
Absorption |
70.0 |
% |
>70 |
% |
PO, oral; |
DRUGBANK |
Bioavailability |
4.0 |
% |
4 |
% |
PO, oral; |
DRUGBANK |
Bioavailability |
15.0 |
% |
15 |
% |
PO, oral; high-fat meal; |
DRUGBANK |
T Max |
4.5 |
h |
3-6 |
h |
PO, oral; Active metabolite; |
DRUGBANK |
Tss |
144.0 |
h |
4-8 |
day |
Oral multiple dose; |
DRUGBANK |
Clearance |
140.0 |
L/h |
130-150 |
L/h |
intravenous injection, IV; |
DRUGBANK |
Clearance |
2.0 |
L/h/kg |
33.33 |
ml/min/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Volume of Distribution |
1300.0 |
L |
1200-1400 |
L |
at steady state; intravenous injection, IV; |
DRUGBANK |
Volume of Distribution |
20.0 |
L/kg |
20 |
L/kg |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Half-life |
16.0 |
h |
13-19 |
h |
elimination half-life; |
DRUGBANK |
Half-life |
16.0 |
h |
16 |
h |
intravenous injection, IV; human, homo sapiens; |
Human Intravenous Pharmacokinetic Dataset |
Toxicity LD50 |
2000.0 |
mg/kg |
>2000 |
mg/kg |
PO, oral; Rattus, Rat; |
DRUGBANK |
Eliminate Route |
84.0 |
% |
~84 |
% |
Faeces excretion; PO, oral; |
DRUGBANK |
Eliminate Route |
6.0 |
% |
6 |
% |
Urinary excretion; PO, oral; |
DRUGBANK |
Protein Binding |
99.7 |
% |
99.7 |
% |
plasma proteins; high protein binding; |
DRUGBANK |